Clinical Professor of Medicine.
1096-9098/asset/JSO_centre.gif?v=1&s=b44eca97c40499f32ff14e6985e50766d4683ad2)
Review Article
Guidelines for lymphoscintigraphy and F18 FDG PET scans in Melanoma
Article first published online: 19 AUG 2011
DOI: 10.1002/jso.21770
Copyright © 2011 Wiley-Liss, Inc.
Issue
Journal of Surgical Oncology
Special Issue: Seminars in Surgical Oncology: Melanoma
Volume 104, Issue 4, pages 405–419, September 2011
Additional Information
How to Cite
Uren, R. F., Howman-Giles, R., Chung, D. and Thompson, J. F. (2011), Guidelines for lymphoscintigraphy and F18 FDG PET scans in Melanoma. J. Surg. Oncol., 104: 405–419. doi: 10.1002/jso.21770
- †
Clinical Professor of Medicine.
- ‡
Professor of Melanoma and Surgical Oncology.
Publication History
- Issue published online: 17 AUG 2011
- Article first published online: 19 AUG 2011
- Manuscript Accepted: 9 SEP 2010
- Manuscript Received: 10 AUG 2010
- Abstract
- Article
- References
- Cited By
Keywords:
- lymphoscintigraphy;
- F-18 PET/CT;
- melanoma
Abstract
Melanoma has a high potential to develop metastases. Accurate staging is essential for appropriate management. Sentinel node (SN) status is a powerful prognostic factor in early stage melanoma. Staging is assisted by SN biopsy after lymphoscintigraphy to locate all true SNs prior to biopsy. PET using F18-FDG can detect metastases and is used to restage patients with AJCC Stages III and IV disease before planning surgery with curative intent. J. Surg. Oncol. 2011; 104:405–419. © 2011 Wiley-Liss, Inc.